The Dental Clinics of North America 1994: Vol 38 Index

21 Pages·1994·4.1 MB·English

CUMULATIVE INDEX 1994
Volume 38
January THE CLINICAL APPROACH TO RADIOLOGIC DIAGNOSIS, pages
1-191
April BASIC PROCEDURES IN ORAL SURGERY, pages 193-359
July PRACTICAL CONSIDERATIONS IN SPECIAL PATIENT CARE,
pages 361-584
October DRUGS PRESCRIBED TO DENTAL PATIENTS, pages 585-805
Note: Page numbers of article titles are in boldface type
Absorption, drug interactions affecting, 771 Adults, anxiolytic therapy in, intravenous
of para-aminophenols, 641 sedation for, 612-613
of salicylates, 637 oral sedation for, 610-611
pharmacokinetics of, 590-592 Advance directives, for health care, 561-
in elderly, 757-758 562
Abuse, ethical responsibility of dentist in, Adverse drug effects, 769-783
569-572 in pediatric patient, 734
Acetaminophen, 640-643 Aging, normative changes in, 509
adverse effects of, 642-643 pharmacodynamic / pharmacokinetic
drug interactions with, 532 changes with, clinical drug use mod-
for acute orofacial pain, 661 ifications for, 762-765
opioids with, in oral surgery, 247 Agonists, definition of, 586
pharmacodynamics of, 641 AIDS, dentist’s response to, 419-420
pharmacokinetics of, 641-642 Alcohol, and head and neck cancer, 427-
pharmacotherapeutics of, 642 428
use in children, 736-737
Alfentanil, anxiolytic therapy with, 606
Acetylsalicylic acid. See also Aspirin;
sedation with, 614
Salicylates.
Allergic intolerance, to acetaminophen, 642
and acetaminophen, 633-644
to aspirin, 639
Acquired immunodeficiency syndrome,
dentist’s response to, 419-420 Allergic reactions, drug-induced, 776-778
Activated partial thromboplastin time, in Allergies, history of, 363
bleeding disorders, 467 in medically compromised patient, and
Activity limitations, of elderly, self- treatment risk, 385
reported, 515-516 Alprazolam, for chronic orofacial pain,
Acyclovir, drug interactions with, 532 682-683
for dental lesion associated with HIV in- for sedation, 614
fection, 410-411 Alveolar bone loss, and surgical extraction,
Adenocystic carcinoma, radiolucencies 232
with, 98-99 in diabetes mellitus, 454
Adenomatoid odontogenic tumor, Alveolar crest, in moderate periodontitis,
radiographic appearance of, 56-57
Adrenal suppression, medications causing, Alveolar dehiscence, in moderate
treatment modifications for, 535 periodontal disease, 25
786 CUMULATIVE INDEX 1994
Alveolar ridge resorption, in elderly, 508 clinical features of, 75-76
Alzheimer’s disease, dental care in, histopathologic findings in, 77
informed consent for, 555-557 radiographic features of, 76-77
Ameloblastic fibro-odontoma, radiographic treatment of, 77
appearance of, 55-56 Angioedema, drug-induced, 774
Ameloblastic fibroma, radiographic with local anesthetics, 625
appearance of, 54-55 Angular cheilitis, associated with HIV
Ameloblastoma, 66-69 infection, diagnosis and treatment of,
clinical features of, 66-67 409
histopathologic findings in, 68 Ankylosis, of temporomandibular joint,
radiographic features of, 67-68 radiographic appearance of, 171
treatment of, 68-69 Ansaid, in oral surgery, 239-240
American Heart Association Antagonists, definition of, 586
recommendations, for antibacierial Antibacterial prophylaxis, 707-718
prophylaxis, 709-710 for asplenic patient, 712-713
Americans with Disabilities Act, and dental for cardiac patient, 707-709
care accessibility, 569-570 for diabetic patient, 714-715
Amides, for local anesthesia, 629 for neutropenic patient, 715-716
Aminoglycosides, drug interactions with, with kidney disease, 713-714
532 with prosthetic joints, 711-712
Amitriptyline, for chronic tension headache Antibiotics, drug interactions with, 532
differential diagnosis, 675 for pediatric patient, 747-749
for postviral neuralgia differential diag- in bacteremia, 383-384
nosis, 677 in endodontic surgery, 319
Amoxicillin, drug interactions with, 532 in medically compromised patient, 381-
for antibacterial prophylaxis, 710 402
for bacterial endocarditis prevention, treatment risk with, 386
389-390 in odontogenic infections, effectiveness
for odontogenic infections, 698 of, antibiotic factors in, 694-695
Ampicillin, drug interactions with, 700 drug interactions and, 698
for antibacterial prophylaxis, 710 patient-specific factors in, 695-698
for bacterial endocarditis prevention, 390 frequently used, 698-703
for odontogenic infections, 698 selection rationale for, 703-704
in oral surgery, 248-249 oral, cost of, 697
Analgesics, drug interactions with, 532 dental use of, 703
efficacy of, pain mechanisms underlying, pharmacodynamic/ pharmacokinetic
646-647 changes with age, clinical drug use
for chronic pain management, 678 modifications for, 765
in endodontic surgery, 319 prophylactic, with prosthetic joints, 391
para-aminophenols as, 641 systemic, in oral surgery, 248-249
pharmacodynamic/ pharmacokinetic Anticalculous agents, supragingival plaque
changes with age, clinical drug use reduction with, 721
modifications for, 763-764 Anticholinergics, drug interactions with,
salicylates as, 634, 636 533
use in children, 736-738 Anticoagulant therapy, dental treatment in,
Anaphylaxis, drug-induced, 777 476-477
Anatomic contraindications, to endodontic Antidepressants, for chronic pain
surgery, 306 management, 678, 680-681
Anemia, management of, in head and neck Antifungals, drug interactions with, 532
cancer, 438 in medically compromised patient, treat-
sickle cell, antibiotic considerations in, ment risk with, 387
395 Antihistamines, drug interactions with, 533
Anesthesia, in disabilities, 492 pharmacodynamic/ pharmacokinetic
Anesthetics, drug interactions with, 532 changes with age, clinical drug use
in oral surgery, local long-acting, 245- modifications for, 765
246 Anti-inflammatory effect, salicylates and,
topical, 244-245 636
local, 619-632. See also Local anesthetics. Anti-inflammatory medications, in oral
Aneurysmal bone cyst, 75-77 surgery, 238-241
CUMULATIVE INDEX 1994 787
Antimicrobials, in odontogenic infections, dosage of, 638
frequently used, 698-703 drug interactions with, 532
in periodontal practice, 719-731 for acute orofacial pain, 661
subgingival plaque reduction with, 726- forms of, pharmacotherapeutics of, 637-
727 638
supragingival plaque reduction with, opioids with, in oral surgery, 247
725-726 systemic toxicity with, 640
systemic therapy with, indications for, therapy with, dental treatment in, 473
727-729 use in children, 737
Antiplaque agents, supragingival plaque Asplenic patient, antibacterial prophylaxis
reduction with, 721 for, 712-713
Antipyresis, para-aminophenols and, 641 Asplenism, antibiotic considerations in,
salicylates and, 636 394-395
Antirejection drugs, in medically Asthma, dental management with, 373
compromised patient, treatment risk Atopy, drug-induced, 778, 781
with, 386 Atrophic glossitis, in elderly, 506
Anti-thrombotic effect, salicylates and, 636 Autism, related oral conditions in, 486
Antivirals, drug interactions with, 532
Autoimmune lesions, HIV-associated,
in medically compromised patient, treat-
diagnosis and treatment of, 416-418
ment risk with, 387
Autonomy, of elderly, and dental care,
Antral mucosal thickening, radiographic
516-517
appearance of, 158
paternalism vs, in special care patient,
Antroliths, radiographic appearance of, 164
553-554
Anxiolytic therapy, 603-617
Azithromycin, drug interactions with, 700
barbiturates, 607-608
for odontogenic infections, 699
benzodiazepines, 604—605
chloral hydrate, 609
drug interactions in, 533
for chronic pain management, 678
Bacteremias, and dental procedures, 381-
for pediatric patient, 738-746
chloral hydrate, 740-741
duration of, 383
diazepam, 743-744
factors influencing, 381-382
hydroxyzine, 741-742
meperidine, 745-746 qualitative nature of, 383
midazolam, 744-745 role of antimicrobials in, 383
promethazine, 742-743 Bacterial endocarditis, prevention of, 388-
intravenous sedation, 611-613, 616 390
ketamine, 608 Bacterial flora, in pediatric patient,
opioids, 605-607 pharmacologic principles of, 734
oral sedation, 610-611 Bacterial infection, HIV-associated,
propofol, 608-609 diagnosis and treatment of, 413
reversal agents for, 613 in head and neck cancer, management
techniques of, 609 of, 437-438
Apex location, in endodontic surgery, 316 Barbiturates, anxiolytic therapy with, 607-
Aphthous ulcers, HIV-associated, diagnosis 608
and treatment of, 416-418 drug interactions with, 533
Apical curettage, in endodontic surgery, Basal cell carcinoma syndrome,
303 radiographic appearance of, 66
Apicoectomy, anterior, 301-324 Benzodiazepines, anxiolytic therapy with,
endodontic surgery vs, 301 604-605
in endodontic surgery, 303-305, 316-317 drug interactions with, 533
Arch length discrepancy, and third molar for chronic orofacial pain, 682-683
removal, 256 Beta-adrenergic blockers, disease
Arthus reaction, drug-induced, 777, 779 interactions with, 772-773
Aspiration biopsy, of oral mucosa, 297-298 Bicuspidizing, for surgical removal of
Aspirin. See also Salicylates. mandibular first molar, 223
adverse reactions to, differential diagno- Biliary excretion, drug interactions
sis of, 639 affecting, 772
and acetaminophen, properties of, 641 pharmacokinetics of, 594
788 CUMULATIVE INDEX 1994
Biopsy, in head and neck cancer diagnosis, Burkitt’s lymphoma, radiolucencies with,
431-432 102-105
of oral mucosa, 279-300. See also Oral Burning mouth, in diabetes mellitus, 449-
mucosa. 450
Biotransformation, of para-aminophenols,
641-642
of salicylates, 637
pharmacokinetics of, 592-593 Calcium channel blockers, disease
Bleeding, in endodontic surgery, 319 interactions with, 773
medications causing, treatment modifica- Cancer, antibiotic considerations in, 393
tions for, 534 dental management with, 375
Bleeding disorders, common, and dental head and neck, nonsurgical management
treatment, 469-471 of, 425-445
dental evaluation in, 466—468 radiopacities with, 131-133
treatment of, 465-482 Candidal stomatitis, in elderly, 508
Bleeding gums, medication-induced, 530 Candidiasis, HIV-associated, diagnosis and
Bleeding time, in bleeding disorders, 467 treatment of, 407—409
Blindness, related oral conditions in, 487 in diabetes mellitus, 450
Blood count, knowledge of, in treating in head and neck cancer, management
HIV-infected patient, 405 of, 435-437
Body composition, of pediatric patient, medication-induced, 530
pharmacologic principles of, 733 Capability, of elderly, and dental care, 514-
Bone, central hemangioma of, 77-80 516
clinical features of, 77-78 Capsaicin cream, for chronic orofacial pain,
histopathologic findings in, 79 683
radiographic features of, 78-79 Carbamazepine, for trigeminal neuralgia
treatment of, 79-80 differential diagnosis, 676
Paget’s disease of, radiopacities with, Carcinogens, industrial, and head and neck
147-152 cancer, 429
removal of, for impacted third molars, Carcinoma, oral, TNM classification for,
mandibular, 263-265 433
maxillary, 273 radiolucencies with, adenocystic, 98-99
vascular lesions of, clinical features of, mucoepidermoid, 96-98. See also Mu-
77-78 coepidermoid carcinoma.
histopathologic findings in, 79 squamous cell, 93-96. See also Squa-
radiographic features of, 78-79 mous cell carcinoma.
treatment of, 79-80 Cardiac collapse, with local anesthetic, 624
Bone cyst, aneurysmal, 75-77 Cardiac dysfunction, drug-induced, 776
clinical features of, 75—76 Cardiac pacemaker, antibacterial
histopathologic findings in, 77 prophylaxis with, 709
radiographic features of, 76-77 Cardiac patient, antibacterial prophylaxis
treatment of, 77 for, 707-709
Bone density, and surgical extraction, 233- Cardiovascular disease, antibiotic
234 considerations in, 387-389
Bone loss, alveolar, and surgical extraction, dental management with, 369-373
232 Cardiovascular grafts, antibacterial
horizontal, in severe periodontitis, 26 prophylaxis with, 709
vertical, in moderate periodontal disease, Caries, 14-20
24 facial/lingual, 16, 20
Bone marrow, hematopoietic defect of, in diabetes mellitus, 451
radiographic appearance of, 38—40 in disabled persons, prevention of, 484-
Brain injury, related oral conditions in, 488 488
Bruxism, in disabled persons, management interproximal, 14-16
of, 489 occlusal, 16
Buccal mucosa fibroma, excisional biopsy radiologic interpretation of, 13-31
of, 296 recurrent, and restorative materials, 19-
Bulla, definition of, 281 20
Bupivacaine, in oral surgery, 245-246 root, 16-19
CUMULATIVE INDEX 1994 789
Carotidynia, differential diagnosis of, in cancer populations, selected studies
medications useful in, 675 of, 436
Cellulitis, in pediatric patient, antibiotics supragingival plaque reduction with,
for, 749 724-725
Cemental dysplasia, periapical, clinical Chondrosarcoma, radiolucencies with, 100-
features of, 127, 137-138 102
differential diagnosis of, 128-129 radiopacities with, 132
histologic findings in, 128 Chronic obstructive pulmonary disease,
management of, 129 dental management with, 373
radiographic appearance of, 127-128, Clarithromycin, drug interactions with, 700
138-139 for odontogenic infections, 699
radiopacities with, 126-129, 137-139 Clindamycin, drug interactions with, 532,
treatment of, 139 700
Central giant cell granuloma, radiographic for antibacterial prophylaxis, 710
appearance of, 69-71 for bacterial endocarditis prevention,
Cephalosporins, dental use of, 702 389-390
drug interactions with, 532, 700 for odontogenic infections, 699
for odontogenic infections, 698 in oral surgery, 248-249
Cerebral palsy, dental management with, Clinician, role in consent process, 559
376 Closure, for impacted third molars,
related oral conditions in, 487 mandibular, 267-270
Cerebrospinal fluid shunt, antibacterial maxillary, 275
prophylaxis with, 709 Clotrimazole, for HIV-associated fungal
Cerebrovascular accident, dental lesions, 408, 409
management with, 377 Cluster headaches, differential diagnosis of,
in elderly, impact on dental care, 510- medications useful in, 673-674
512 Coagulation, cascading pathways for, 480
Cervical burnout, root caries with, 17-18 following tissue injury, mechanisms of,
Chalazion forceps and retractor, 292 79
Cheilitis, angular, HIV-associated, screening tests of, interpretation of, 468
diagnosis and treatment of, 409 Coagulopathies, inherited, dental treatment
Chemical restraints, for special care in, 473-476
patients, 564 Codeine, for chronic orofacial pain, 679
Chemotherapy, dental management with, in oral surgery, 246-248
375 Cognitive skills, in medical history, 365-
in head and neck cancer, 434 366
in medically compromised patient, treat- Combination analgesics, use in children,
ment risk with, 386 738
Cherubism, 70-73 Communication board, for stroke patient,
clinical features of, 71-72 512
histopathologic findings in, 73 Competence, for informed consent, 558, 560
radiographic features of, 72-73 Compliance, in elderly, 761
treatment of, 73 in pediatric patient, pharmacologic prin-
Children. See also under Pediatric. ciples of, 734-735
analgesic use in, 736-738 in pharmacotherapeutics, 599-600
anxiolytic therapy in, 610-612 Computed tomography, indications for, 8—
dentistry in, pharmacologic considera- 9
tions in, 733-753 Condensing osteitis, 27
Chloral derivatives, pharmacodynamic/ radiopacities with, 118-120
pharmacokinetic changes with age, Condylar aplasia/hypoplasia, of
clinical drug use modifications for, 765 temporomandibular joint, radiographic
Chloral hydrate, anxiolytic therapy with, features of, 180
609 Condylar hypeytrophy /hyperplasia, of
in pediatric patient, 740-741 temporomandibular joint, radiographic
sedation with, 615 features of, 180-181
Chlorazepate, anxiolytic therapy with, 605 Congenital disorders, of
Chiorhexidine, for dry socket prevention, temporomandibular joint, radiographic
250 features of, 180-181
790 CUMULATIVE INDEX 1994
Congenital heart disease, dental supragingival plaque reduction with,
management with, 371-372 720-723
Congestive heart failure, dental Dentigerous cyst, radiographic appearance
management with, 372 of, 52-54
Consultation reports, 365 Dentist-physician communication,
Cortical trephination, in endodontic concerning elderly, 513-514
surgery, 302 concerning human immunodeficiency vi-
Corticosteroids, drug interactions with, 533 rus, 405-406
Cough reflex, impaired, in stroke patient, Dentoalveolar trauma, in pediatric patient,
512 antibiotics for, 749
Coumarin therapy, dental treatment in, 476 Denture(s), for disabled patient, 494
Crestal tissue, mobile, removal of, 210 ill-fitting, palatal papillary hyperplasia
Crown, condition of, in surgical extraction, with, 208
226-227 immediate, 211-215
Crown/root ratio, as contraindication to classic, 212-215
endodontic surgery, 306-307 stage I, 213-214
Crust, definition of, 281 stage II, 214-215
Curettage and biopsy, in endodontic temporary, 215
surgery, 316 Dependence, of elderly, and dental care,
Cysts, of maxillary sinus, radiographic 514-515
appearance of, 162-164 Devitalized tooth, endodontic surgery for,
Cytomegalovirus, HIV-associated,
diagnosis and treatment of, 411, 413 Dexamethasone, in intentional replantation,
Cytotoxic hypersensitivity, drug-induced, 331
777-778 Diabetes mellitus, 447-463
antibacterial prophylaxis in, 714-715
antibiotic considerations in, 393-394
classification and pathophysiology of,
Deafness, related oral conditions in, 488 448
Decision-making capacity, for informed complications of, 449
consent, 558, 560 dental management in, 454-459
of elderly, and dental care, 517 patient evaluation, 454-456
Degenerative joint disease, of patient management, 456-458
temporomandibular joint, radiographic emergencies in, during dental care, 458-
appearance of, 171-174, 176 459
Delayed hypersensitivity reaction, drug- epidemiology of, 447-448
induced, 777-778 in elderly, impact on dental care, 510
Dementia, dental management with, 378 medical treatment of, 453-454
related oral conditions in, 487 oral manifestations of, 449-453
Dental care, access to, by disabled persons, screening tests for, 455
494-496 signs and symptoms of, 448-449
by special care patients, 566-569 Diabetic shock, during dental care, 458-459
Dental caries, in diabetes mellitus, 451 Diazepam, anxiolytic therapy with, 604—
in disabled persons, prevention of, 484— 605
488 in pediatric patient, 743-744
Dental disease, and bacteremia, 382 for sedation, 614
in disabled persons, prevention of, 484— in oral surgery, 241
488 Diet, and head and neck cancer, 428-429
Dental infection, in pediatric patient, Difiunisal, for pain, acute, 652
antibiotics for, 749 maximum recommended dosages, 663
Dental patient, diabetic, 447-463 in oral surgery, 239
Dental practitioners, for nursing home Digital imaging, indications for, 9-10
patients, 543-544 Digital subtraction imaging, of alveolar
Dental restorations, in elderly, 503 bone loss, 30
Dental Risk Assessment and Prognosis Diphenhydramine, for sedation, 615
Evaluation Scale, 367-369 Disabilities, 483-498
Dentate patients, radiographic and access to care, 494—496
recommendations for, 5-6 behavior management in, 491-493
Dentifrices, properties of, 722 communication in, 490
CUMULATIVE INDEX 1994 791
coordination of care in, 493 with local anesthetics, 626
informed consent in, 490—491 Drug reactions, in polymedication patient,
medically compromising conditions vs, 526
362 Drug therapy, oral manifestations of, 530
modified radiographic techniques in, Dry sockets, medication for, 249-251
491-492 prevention, 250
oral conditions related to, 486—488 treatment, 250-251
treatment considerations in, 489-490, Dysgeusia, management of, in head and
493-494 neck cancer, 438
Distoangular impaction, definition of, 259
Distribution, drug interactions affecting,
771
of para-aminophenols, 641 Economic barriers, to dental care, by
of salicylates, 637 special care patients, 566-567
pharmacokinetics of, 592 Edentulous areas, in elderly, 506
in elderly, 758 Edentulous patients, radiographic
Do not resuscitate /intubate orders, and recommendations for, 6
dental team, 562 Elderly, autonomy of, and dental care, 516-
Dolobid, in oral surgery, 239 517
Dose-response relationship, of drugs, 587- capability of, and dental care, 514-516
588 characteristic oral findings in, 501
individual variations in, 589 characteristics of, effect on dental care
pharmacodynamics of, 587-589 provision, 539-540
Down syndrome, related oral conditions in, dental assessment of, 502
486 dental care of, 499-523
Drilac, for dry socket prevention, 250 impact of diseases on, 509-511
Drug(s), disposition of, in pediatric patient, oral factors in, 502-507
pharmacologic principles of, 733-734 occlusal relationships, 507
pharmacologic interactions of, 770 oral hygiene, 504-505
physiologic interactions of, 770-771 oral mucosa, 505-507
receptors for, alterations in, 771 oral secretions, 505
pharmacodynamics of, 585-586 periodontal tissues, 503-504
route of administration of, and absorp- removable prostheses, 507
tion, 591 restorations, 503
in pediatric patient, 735 root caries, 504—505
solubility of, 590 teeth, 503
Drug-disease interactions, 772-773 tooth loss, 505
Drug effects, adverse, 769-783 pharmacologic considerations in, 755-
increased, with age, 757 767
Drug-induced illness, 773-778 systemic factors in, 507-514
accurate diagnosis of, 779-780 dentist-physician communication con-
in oral cavity, 773-775 cerning, 513-514
need for treatment of, critical assessment dependence of, and dental care, 514-515
of, 780 finances of, and dental care, 518-520
systemic, 775-776 long-term care needs of, 538
therapy for, continuous reassessment of, medication compliance by, 761
782 medication prescribing for, principles of,
Drug interactions, 532-533, 770-772 760-761
affecting absorption, 771 normative age changes in, 509
affecting biliary excretion, 772 oral and circumoral findings in, 508
affecting distribution, 771 pharmacodynamics in, 756
affecting metabolism, 772 pharmacokinetics in, 756-759
affecting renal excretion, 772 projected population of, 500
and antibiotic effectiveness, in odonto- Electrosurgical units, in oral mucosa
genic infections, 698 biopsy, 287
and pharmacotherapeutics, 598-599 Elliptical incision, in oral mucosa biopsy,
pharmacodynamic, 770-771 286
pharmacokinetic, 771-772 Endarteritis, obliterative, in head and neck
software for, 527 cancer, management of, 439-441
792 CUMULATIVE INDEX 1994
Endocarditis, bacterial, prevention cf, 388- of para-aminophenols, 642
390 of salicylates, 637
regimens for, 370 pharmacokinetics of, 593-594
infective, prophylaxis for, in oral sur- Exfoliative cytology, in head and neck
gery, 248-249 cancer diagnosis, 431
Endodontic surgery, apex location in, 316 of oral mucosa, 298-299
apicoectomy vs, 301 Exostosis, 120-124
clinical technique in, 311-320 clinical findings with, 121-122
flap design, 311-315 radiographic findings with, 122-123
components of, 302-306 Extraction(s), in intentional replantation,
apical curettage, 303 333
apicoectomy, 303-305, 316-317 surgical, 217-236. See also Surgical extrac-
cortical trephination, 302 tions.
retroseal, 305-306
contraindications to, 306-307
curettage and biopsy in, 316
for tooth failure diagnosis, 310 Facial form, and impacted mandibular
future, 320-322 third molar removal, 260
postsurgical follow-up in, 319-320 Facial neuritis, medication-induced, 530
retropreparation and filling in, 317-318 Falls, drug-induced, 775
suturing in, 318-319 Fecal excretion, pharmacokinetics of, 594
Endodontic treatment, conventional, Feldene, in intentional replantation, 331
periapical surgery as alternative to, Fentanyl, anxiolytic therapy with, 606
309 sedation with, 614
in bleeding disorders, 470 Fibroma, ameloblastic, radiographic
previous, and surgical extraction, 232 appearance of, 54-55
Envelope flap, definition of, 220-221 Fibro-odontoma, ameloblastic, radiographic
in impacted mandibular third molar re-
appearance of, 55-56
moval, 261-262
Fibrosarcoma, radiolucencies with, 100-102
Environmental factors, and head and neck
Fibrous dysplasia, 142-145
cancer, 429
clinical features of, 143
Epinephrine, and local anesthetics, 627
histopatholgic findings in, 145
Epithelial odontogenic tumor, calcifying,
radiographic appearance of, 143-144
radiographic appearance of, 57-59
treatment of, 145
Epithelial peeling, in oral mucosa biopsy,
Fibrous healing defect, radiographic
287
appearance of, 40-41
Erosion, definition of, 281
Field cancerization, and head and neck
Eruption cyst, radiographic appearance of,
52 cancer, 429
Erythema multiforme, medication-induced, Filling, in endodontic surgery, 317-318
530, 774 materials for, in intentional replantation,
Erythematous candidiasis, HIV-associated, 334
diagnosis and treatment of, 407-409 Filtration, pharmacokinetics of, 589
Erythromycin, drug interactions with, 532, Finances, of elderly, and dental care, 518-
700 519
for antibacterial prophylaxis, 710 Fine-needle aspiration, in head and neck
for bacterial endocarditis prevention, 389 cancer diagnosis, 431
for odontogenic infections, 698 of oral mucosa, 299
in oral surgery, 248-249 Flabby ridge, augmentation of, 210, 212-
Erythroplakia, with tobacco and alcohol 213
use, 430 Flap design, for impacted third molar
Esters, for local anesthesia, 629 removal, mandibular, 261-263
Ethical issues, in special patient care, 553- maxillary, 270-273
575 in endodontic surgery, 311-315
Etidocaine, in oral surgery, 245-246 attached gingival flap considerations,
Ewing’s sarcoma, radiolucencies with, 107- 313-314
108 general considerations, 312-313
Excretion, of drugs, in pediatric patient, specific considerations, 313
pharmacologic principles of, 734 triangular flap considerations, 315
CUMULATIVE INDEX 1994 793
in surgical extractions, principles of, 218- Globulomaxillary cyst, radiographic
220 appearance of, 45—46
Floor of mouth, biopsy of, 295 Glossitis, atrophic, in elderly, 506
Fluconazole, drug interactions with, 532 medication-induced, 530
for HIV-associated fungal lesions, 408 Gorlin cyst, radiographic appearance of,
Fluorides, supragingival plaque reduction 59-60
with, 723 Gorlin-Goltz syndrome, radiographic
Fluoroquinolones, dental use of, 704 appearance of, 66
drug interactions with, 701 Granuloma, periapical, radiographic
for odontogenic infections, 699 appearance of, 27-28
Flurbiprofen, for pain, acute, 655-656, 661 Granulomatous ulcerations, HIV-
maximum recommended dosages, 663 associated, diagnosis and treatment of,
in oral surgery, 239-240 418-419
Follicular cyst, radiographic appearance of, Guardians, role in consent process, 559
52-54
Foreign bodies, radiopacities with, 129-131
Frenoplasty, 201-204
complications of, 203-204 Hairy leukoplakia, HIV-associated,
excision, 203 diagnosis and treatment of, 411-412
“Z” plasty, 202-203 Head and neck cancer, 425-445
Frenum, maxillary labial, prominent, 201 anatomic sites of, 427
Fungal infection, HIV-associated, diagnosis causes of, 426-429
and treatment of, 407-408 diagnosis of, 430-432
in head and neck cancer, management biopsy, 431
of, 435-437 clinical examination, 430
exfoliative cytology, 431
fine-needle aspiration, 431
radiographic imaging, 431—432
Gag reflex, impaired, in stroke patient, 512
toluidine blue staining, 431
Gagging, medications causing, treatment
epidemiology of, 426
modifications for, 535
infection in, management of, 435-438
Gastric acid levels, in pediatric patient,
mucositis in, management of, 434—435
pharmacologic principles in, 734
obliterative endarteritis /o steoradione-
Gastric emptying, in pediatric patient,
crosis in, management of, 439-441
pharmacologic principles of, 734
oral complications in, acute, 434—438
Gastric irritation/bleeding, aspirin and,
chronic, 439-441
639-640
Gastrointestinal disturbances/bleeding, salivary gland dysfunction in, manage-
drug-induced, 775 ment of, 439
Gelfoam, for dry socket prevention, 250 staging and prognosis in, 432-433
Generalized radiopacities, 137-153 TNM classification for, 433
Gentamicin, for antibacterial prophylaxis, treatment of, 433-441
710 chemotherapy and radiation, 434
for bacterial endocarditis prevention, 390 resection, 433-434
Geriatric dentistry. See under Elderly. Health care, access to, by special care
Giant cell arteritis, differential diagnosis of, patients, 555, 566-569
medications useful in, 674-675 Hearing impairment, related oral
Giant cell granuloma, central, radiographic conditions in, 488
appearance of, 69-71 Heart disease, dental management with,
Gingiva, linear erythema of, HIV- 370-372
associated, diagnosis and treatment of, ischemic, in elderly, impact on dental
413-414 care, 509-510
Gingival flap, attached, components of, 314 Heart failure, congestive, dental
Gingival hyperplasia, drug-induced, 774- management with, 372
775 Heart murmurs, antibacterial prophylaxis
in diabetes mellitus, 451, 453 with, 708
medication-induced, 530 Heart transplant, antibacterial prophylaxis
Gingivitis, necrotizing, HIV-associated, with, 709
diagnosis and treatment of, 413-415 dental management with, 372-373
794 CUMULATIVE INDEX 1994
Heart valve prosthesis, antibacterial antibiotic considerations in, 396
prophylaxis with, 709 dental management with, 375
Hemangioma, bone, central, 77-80. See also dentist-physician interaction concerning,
under Bone. 405-406
Hematologic disorders, dental management dentist’s response to, 419-420
with, 376 epidemiology of, 403-405
Hematopoietic bone marrow defect, Hydroxyzine, anxiolytic therapy with, in
radiographic appearance of, 38-40 pediatric patient, 741-742
Hemodialysis, antibiotic considerations in, sedation with, 615
392 Hypercementosis, radiopacities with, 124—
Hemophilia, dental treatment in, 473-475 126
Hemorrhage, in head and neck cancer, Hyperglycemic crisis, during dental care,
management of, 438 458-459
oral, in acute myelogenous leukemia, 472 Hyperparathyroidism, radiopacities with,
in von Willebrand’s disease, 476 146-147
Hemostasis, agents for, in bleeding Hypersensitivity reactions, drug-induced,
disorders, 471 776
- mechanisms of, 479-481 Hyperventilation syrdrome, with local
Heparin therapy, dental treatment in, 476 anesthetic, 624
Hepatic disease, and antibiotic
Hypnotics, drug interactions with, 533
effectiveness, in odontogenic
Hypoglycemic crisis, during dental care,
infections, 696-697
458
Hepatic effects, of aspirin, 640
Hypotension, orthostatic, in elderly, impact
Hepatic first pass metabolism, in drug
on dental care, 513
biotransformation, 593
medications causing, treatment modifi-
Hepatic metabolism, in elderly, 757-759
cations for, 534
Hepatitis, dental management in, 375
with local anesthetics, 625
Herpes infection, HIV-associated, diagnosis
and treatment of, 408, 410-411
Histiocytosis, Langerhans’ cell, 90-93. See
also Langerhans’ cell histiocytosis.
Ibuprofen, for acute pain, 653-654, 661
HIV-infected patient, treatment of, barriers
maximum recommended dosages, 663
to, 567-568
in intentional replantation, 331
practical considerations in, 403-423
plus codeine, for acute pain, 658-659
Hodgkin’s disease, radiolucencies with,
102-105 maximum recommended dosages,
Homebound/nursing home patients, 663
demographics of, 537-538 plus hydrocodone, for acute pain, 660
dental care for, 537-551 maximum recommended dosages,
commitment to, 543-544 663
delivery of, 544-545 plus oxycodone, for acute pain, 659-660
reimbursement issues in, 547-548 maximum recommended dosages,
setting goals for, 545-546 663
strategy development and initiation of, use in children, 737-738
546-547 Idiopathic osteosclerosis, 113-116. See also
functional status of, definition of, 538- Osteosclerosis.
539 Immune compromise, medications causing,
health in, definition of, 538-539 treatment modifications for, 534—535
oral health characteristics of, differences Immunohistochemical studies, of oral
in, 540-542 mucosa, 299
Horizontal impaction, definition of, 259 Immunosuppressive drugs, in medically
Hospitalizations, in medically compromised patient, treatment risk
compromised patient, and treatment with, 386—387
risk, 385 Impacted third molars, removal of, 255-
Host defense mechanisms, and antibiotic 278. See also Third molars.
effectiveness, in odontogenic Incision lines, in surgical extractions,
infections, 695-696 placement of, 220
Human immunodeficiency virus. See also Incompetence, for informed consent, 558,
HIV-infected patient. 560